CLINICAL_TRIALS
trial_result
· 2019-12-13
Clinical Trial Update: Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno® [Phase 1]
Summary
Phase 1 trial update evaluating safety and tolerability of preservative-free ophthalmic solution PRO-122 vs Krytantek Ofteno in glaucoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Glaucoma | Phase 1 | Status: COMPLETED | Results posted: 2019-12-13